Mode
Text Size
Log in / Sign up
Phase 2 N=54 Randomized Triple-blind Prevention

Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy

Airway Obstruction · Apnea · Hypopnea

Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Aug 2014
Primary outcome: Primary: RI Events in the cNEP Group Compared to the no cNEP Group, Where RI is Defined as Either: i Oxygen Saturation < 90% or ii. Apneas/Hypopneas of > 15 Sec Duration i. Oxygen Saturation <90% ii. Presence of Apneas or Hypopneas — 1.92; 3.5 RI events — p=<0.022

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Airway Management System (AMS) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
5i Sciences, Inc.
Primary completion
Mar 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
RI Events in the cNEP Group Compared to the no cNEP Group, Where RI is Defined as Either: i Oxygen Saturation < 90% or ii. Apneas/Hypopneas of > 15 Sec Duration i. Oxygen Saturation <90% ii. Presence of Apneas or Hypopneas
1.92; 3.5 <0.022 sig
SECONDARY
The Safety of cNEP as Determined by Adverse Events Reported by the Investigators.
SECONDARY
The Incidence of Subjects With One or More RI in the cNEP Group Compared to the no cNEP Group.
SECONDARY
The Frequency of Interventions to Alleviate RI in the cNEP Group Compared to the no cNEP Group.
1; 0

Summary

The primary goal of this study is to determine the effectiveness and safety of delivering continuous negative external pressure (cNEP) to the upper airway as a means of preventing episodes of respiratory impairment (RI) such as hypoxemia, apnea and hypoventilation associated with the use of intravenous sedation in elective colonoscopy in adult patients.

Eligibility Criteria

Inclusion Criteria

  • Male or female subjects undergoing elective colonoscopy at the Study Site who have fewer than three or more than three positive responses on the STOP BANG questionnaire

Exclusion Criteria

  • Presence of severe cardiopulmonary or neurologic disease as determined by the investigator
  • History of vascular fragility associated with cutaneous pressure
  • History of hypersensitivity to silicone
  • Inability to properly fit cNEP collar to the subject
  • The presence of excessive facial hair in the region where the cNEP collar is positioned
  • Known carotid vascular disease, previous major neck surgery or radiation therapy to the cervical region
  • Presence of anatomical abnormalities in the neck or pharyngeal region (such as enlarged tonsils)
  • Inability to provide informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01895062). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search